Cynthia Lambert Hardman, a partner in Goodwin's IP Litigation Group and co-chair of the firm’s PTAB Practice, has over 15 years of experience litigating complex intellectual property cases in U.S. district courts and the U.S. International Trade Commission (ITC). A registered patent attorney, Ms. Hardman also litigates before the U.S. Patent and Trademark Office Patent Trial and Appeal Board (PTAB) in post-grant proceedings such as inter partes reviews (IPRs).
Ms. Hardman represents clients in the pharmaceutical, biosimilar, medical device, nutritional supplement, and consumer product industries. She has significant experience with ANDA patent litigation under the Hatch-Waxman Act, and also litigates cases involving a wide range of products such as spinal fixation devices, home pregnancy tests, and video content analysis systems and software.
Ms. Hardman's practice also extends to pre-litigation counseling, including rendering opinions relating to patentability, infringement, validity and freedom-to-operate issues. She has also conducted due diligence in connection with acquisitions of patent estates.
Ms. Hardman co-founded and co-authors Goodwin’s monthly publication, Keeping Tabs on the PTAB, which provides updates to clients about PTAB, district court, and Federal Circuit decisions that impact post-grant review proceedings. Ms. Hardman is also an editor and regular contributor to the firm’s Big Molecule Watch blog.